Document Type : Original Article


Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Ibadan, Nigeria


Background and aims: Prostate cancer (PCa) is the second most commonly diagnosed cancer in men and its incidence is higher among black folks for reasons yet unclear. Although few risk factors have been linked to the development of PCa among Nigerian men, it remains unclear whether these risk factors modulate the odds of PCa.
Methods: The case-control study comprised forty-three cases and one hundred and twenty-nine age-matched controls (± 5 years) without PCa by prostatic specific antigen (PSA) examination. Conditional logistic regression analysis was employed to identify risk factors associated with PCa at P < 0.05 using SPSS 20.
Results: Increasing age (adjusted odds ratio [AOR]: 2.8; 95% CI: 1.7-4.5) was the strongest risk factor for PCa, followed by increasing age at first sex (AOR: 1.2; 95% CI: 1.1-1.4) and sexual activity (AOR: 0.2; 95% CI: 0.1-0.9) as a protective risk factor against PCa in this Nigerian Population.
Conclusion: The study confirms age as a recognized risk factor and backed evidence for other hypothesized risk factors. The study recommends findings with other confirmatory studies that can help to guide policies for better health care decisions among Nigerian men and interventions centered on routine screening for PSA with an emphasis on the elderly clinic is encouraged.


1.Hoffman, M. WebMD LLC. 2020 Available from: https://www. 
2.International Agency for Research on Cancer (IARC). GLOBOCAN: Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Geneva: World Health Organization; 2018. https:// 
3.American Cancer Society (ACS). Cancer Facts & Figures. Atlanta: ACS; 2019. 
4.Badmus TA, Adesunkanmi AR, Yusuf BM, Oseni GO, Eziyi AK, Bakare TI, et al. Burden of prostate cancer in southwestern Nigeria. Urology. 2010;76(2):412-6. doi: 10.1016/j. urology.2010.03.020. 
5.Ikuerowo SO, Omisanjo OA, Bioku MJ, Ajala MO, Mordi VP, Esho JO. Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination. Pan Afr Med J. 2013;15:129. doi: 10.11604/ pamj.2013.15.129.2489. 
6.Batty GD, Kivimäki M, Clarke R, Davey Smith G, Shipley MJ. Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study. Cancer Causes Control. 2011;22(2):311-8. doi: 10.1007/s10552-010-9691-6. 
7.Caple C, Schub T. Prostate Cancer: Risk Factors and Prevention. Glendale, CA: Cinahl Information Systems; 2013. 
8.McGregor SE, Courneya KS, Kopciuk KA, Tosevski C, Friedenreich CM. Case-control study of lifetime alcohol intake and prostate cancer risk. Cancer Causes Control. 2013;24(3):451-61. doi: 10.1007/s10552-012-0131-7. 
9.Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1977-83. doi: 10.1158/1055-9965.epi-06-0477. 
10.Jiménez-Mendoza E, Vázquez-Salas RA, Barrientos-Gutierrez T, Reynales-Shigematsu LM, Labra-Salgado IR, Manzanilla- García HA, et al. Smoking and prostate cancer: a life course analysis. BMC Cancer. 2018;18(1):160. doi: 10.1186/s12885- 018-4065-7. 
11.Subahir MN, Shah SA, Zainuddin ZM. Risk factors for prostate cancer in Universiti Kebangsaan Malaysia Medical Centre: a case-control study. Asian Pac J Cancer Prev. 2009;10(6):1015- 20. 
12.Hosseini M, SeyedAlinaghi S, Mahmoudi M, McFarland W. A case-control study of risk factors for prostate cancer in Iran. Acta Med Iran. 2010;48(1):61-6. 
13.Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS. Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years’ follow up. BMC Cancer. 2012;12:25. doi: 10.1186/1471-2407-12-25. 
14.Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int. 2004;93(8):1139-50. doi: 10.1111/j.1464- 410X.2004.04795.x. 
15.Wolk A. Diet, lifestyle and risk of prostate cancer. Acta Oncol. 2005;44(3):277-81. doi: 10.1080/02841860510029572. 
16.Ceber E, Çakır D. Dietary patterns affecting prostate cancer: medical education. Turk Klin J Med Sci. 2009;29(3):733-9. 
17.Mazdak H, Mazdak M, Jamali L, Keshteli AH. Determination of prostate cancer risk factors in Isfahan, Iran: a case-control study. Med Arh. 2012;66(1):45-8. doi: 10.5455/ medarh.2012.66.45-48. 
18.Salem S, Salahi M, Mohseni M, Ahmadi H, Mehrsai A, Jahani Y, et al. Major dietary factors and prostate cancer risk: a prospective multicenter case-control study. Nutr Cancer. 2011;63(1):21-7. doi: 10.1080/01635581.2010.516875. 
19.Crawford ED. Epidemiology of prostate cancer. Urology. 2003;62(6 Suppl 1):3-12. doi: 10.1016/j.urology.2003.10.013. 
20.Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett. 2009;282(2):125-36. doi: 10.1016/j.canlet.2008.12.011. 
21.Masko EM, Allott EH, Freedland SJ. The relationship between nutrition and prostate cancer: is more always better? Eur Urol. 2013;63(5):810-20. doi: 10.1016/j.eururo.2012.11.012. 
22.International Agency for Research on Cancer (IARC). World Cancer Report. 1st ed. Lyon, France: IARC; 2014. 
23.Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent. Prostate Cancer. 2013;2013:560857. doi: 10.1155/2013/560857. 
24.International Agency for Research on Cancer (IARC). GLOBOCAN: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in. Geneva: World Health Organization; 2012. 
25.Odedina FT, Ogunbiyi JO, Ukoli FA. Roots of prostate cancer in African-American men. J Natl Med Assoc. 2006;98(4):539-43. 
26.Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, et al. Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer. 2009;4(Suppl 1):S2. doi: 10.1186/1750-9378-4-s1- s2. 
27.Akinremi TO, Ogo CN, Olutunde AO. Review of prostate cancer research in Nigeria. Infect Agent Cancer. 2011;6(Suppl 2):S8. doi: 10.1186/1750-9378-6-s2-s8. 
28.Agalliu I, Adebiyi AO, Lounsbury DW, Popoola O, Jinadu K, Amodu O, et al. The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria. BMC Public Health. 2015;15:425. doi: 10.1186/s12889-015-1754-x. 
29.American Cancer Society (ACS). Prostate Cancer Early Detection, Diagnosis, and Staging. ACS; 2019. 
30.Ambs S, Alexander R, Lee D. A Case-Control Study of Prostate Cancer in the Greater Baltimore Area. An Epidemiological Study of Genetic and Environmental Risk Factors for Prostate Cancer in African-American and Caucasian Males. 2012. study_protocol8.pdf. 
31.Ganesh B, Saoba SL, Sarade MN, Pinjari SV. Risk factors for prostate cancer: an hospital-based case-control study from Mumbai, India. Indian J Urol. 2011;27(3):345-50. doi: 10.4103/0970-1591.85438. 
32.Bashir MN, Ahmad MR, Malik A. Risk factors of prostate cancer: a case-control study in Faisalabad, Pakistan. Asian Pac J Cancer Prev. 2014;15(23):10237-40. doi: 10.7314/ apjcp.2014.15.23.10237. 
33.American Cancer Society (ACS). Cancer Facts & Figures. Atlanta: ACS; 2015. 
34.Marston M, Slaymaker E, Cremin I, Floyd S, McGrath N, Kasamba I, et al. Trends in marriage and time spent single in sub-Saharan Africa: a comparative analysis of six population-based cohort studies and nine Demographic and Health Surveys. Sex Transm Infect. 2009;85 Suppl 1:i64-71. doi: 10.1136/sti.2008.034249. 
35.Hennis AJ, Wu SY, Nemesure B, Leske MC. Urologic characteristics and sexual behaviors associated with prostate cancer in an African-Caribbean population in Barbados, West Indies. Prostate Cancer. 2013;2013:682750. doi: 10.1155/2013/682750. 
36.Jian Z, Ye D, Chen Y, Li H, Wang K. Sexual activity and risk of prostate cancer: a dose-response meta-analysis. J Sex Med. 2018;15(9):1300-9. doi: 10.1016/j.jsxm.2018.07.004. 
37.Del Rosario AD, Bui HX, Abdulla M, Ross JS. Sulfur-rich prostatic intraluminal crystalloids: a surgical pathologic and electron probe x-ray microanalytic study. Hum Pathol. 1993;24(11):1159-67. doi: 10.1016/0046-8177(93)90210-8. 
38.Svatek RS, Karam JA, Rogers TE, Shulman MJ, Margulis V, Benaim EA. Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens. Prostate Cancer Prostatic Dis. 2007;10(3):279-82. doi: 10.1038/sj.pcan.4500954.